Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea
· Delayed Price · Currency is KRW 5,710.00
-160.00 (-2.73%)
At close: Dec 5, 2025
Hyundai Bioscience Company Description
Hyundai Bioscience Co., Ltd. operates as a biotechnology company.
The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19.
The company was founded in 2000 and is based in Seoul, South Korea.
Hyundai Bioscience Co., Ltd.
| Country | South Korea |
| Founded | 2000 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 69 |
Contact Details
Address: 150, Bugahyeon-ro Seoul, Gyeongsangbuk-do 03759 South Korea | |
| Phone | 82 1 544 3194 |
| Website | hyundaibioscience.com |
Stock Details
| Ticker Symbol | 048410 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7048410005 |
| SIC Code | 2844 |